Supernus Pharmaceuticals buy klostergang
Start price
01.06.15
/
50%
€12.78
Target price
07.12.15
€17.00
Performance (%)
4.13%
End price
07.12.15
€13.30
Summary
This prediction ended on 07.12.15 with a price of €13.30. With a performance of 4.13%, the BUY prediction by klostergang for Supernus Pharmaceuticals closed with a slight gain. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Supernus Pharmaceuticals | -0.467% | -0.467% | 34.810% | 17.033% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% | 58.100% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% | 84.363% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% | 64.836% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% | 58.669% |
Comments by klostergang for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Entwicklung und Vermarktung von Produkten für die Behandlung des Zentralnervensystems (ZNS):
Seit 2013 mit Oxtellar XR ® und Trokendi XR ®, zwei neuartige Neurologie Produkte für die Behandlung von Epilepsie, mit steigenden Verkaufszahlen.